cerrar
Tagged with Opinion,

How Big Pharma Succeeds In The Era Of Digital Transformation
Much has been made of how Big Pharma needs to learn from Big Tech in order to fully adapt to the digital age. Here, pharma industry veteran Richard…

How US Healthcare Can Better Accommodate Cell & Gene…
PhRMA's Anne McDonald Pritchett PhD highlights the remarkable development of cell and gene therapies in recent years and the three ways in which the…

Advanced Therapy Medicinal Products: The Right Time for Hope?
Pierre Meulien of the Innovative Medicines Initiative (IMI) highlights why cell and gene therapies seem finally braced for mainstream adoption as well…

The USA’s Safe Importation Action Plan: Trump’s Pharma…
In a bid to make tangible progress on the issue of lowering prescription drug pricing before the 2020 presidential election, the Trump administration…

Proposed Solutions to the Access Challenges Facing Cancer…
Janssen's EMEA market access head Martin Price outlines the regulatory changes that need to be made for patients across Europe to better access…

History Repeats with the Release of the 2019 WHO Essential…
Brendan Shaw, Principal of Shawview Consulting and Adjunct Senior Lecturer at the University of New South Wales, shares highlights from the 2019 World…

Japan: Reforming Healthcare in the Age of Ageing
Japan’s Opportunity to Establish a Blueprint for the World: Janssen Japan's Chris Hourigan makes the case for increased investment in, and access…

The Ideal Pharma Country Manager: Turkey (Stanton Chase)
Şükran Tümay, a senior partner at executive search and assessment firm Stanton Chase in Turkey, highlights the evolving profiles she looks for when…

Tackling the Talent Gap in Cell & Gene Therapy
Rare diseases and cell and gene therapy executive recruitment specialist Steve Smith outlines six key strategies for attracting and retaining talent…

Precision Medicine and its Impact on the Global Therapeutic…
Frost & Sullivan's Senior Research Analyst, Aarti Chitale looks at the sizeable impact that precision medicine, especially regenerative medicine,…

Speeding up Regulatory Submissions Through Continuous Publishing
Veeva Systems Europe’s Paul Attridge highlights how a switch to a continuous model for regulatory operations could allow biopharmaceutical companies…

US Pharma Could do a Lot More to Embrace the Consumer
PwC's Kelly Barnes examines how the US pharmaceutical sector is having to rethink its relationship with consumers, experimenting with new and…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here